论文信息 - A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer - 字舞流文

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

E. Winer | M. Cotreau | J. Beckman | A. Strahs | M. Scheulen | H. Richly | M. Dickler | E. Mayer | S. Agarwal | L. Steelman | Eric P. Winer | A. Duarte | E. Winer